The purpose of this study was to develop a nasal in situ gel system for Radix Bupleuri employing gellan gum as a polymer. Radix Bupleuri in situ gel containing 0.2 mL essential oil extracted from 450 g Radix Bupleuri, proper solubilizing agents and gellan gum (0.5% w/v) was prepared and characterized. The antipyretic effect produced by in situ gel formulation was investigated in fevered rabbits and compared to an intranasal solution. The resulting in situ gel was a clear and light-yellow liquid, with viscosity of 346 mPa x s and caproic acid content of 1.31 +/- 0.01 mg/mL. Intranasal administration of this preparation to fevered rabbits decreased body temperature markedly (1.1 degree C at the doses of oil from 1.5 g Bupleuri/body) and the effect could last for 20-30 h. The results suggest that Radix Bupleuri in situ gel can be greater effective than the solution in the treatment of fever.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02993971DOI Listing

Publication Analysis

Top Keywords

situ gel
24
radix bupleuri
20
gellan gum
8
bupleuri situ
8
fevered rabbits
8
situ
6
gel
6
radix
5
bupleuri
5
novel nasal
4

Similar Publications

A novel isopthalamide based receptor HL2 featuring two p-benzoic acid units has been synthesised and its anion binding properties analysed by H-NMR spectroscopy in DMSO-d/0.5 % HO. As expected, in the presence of tetrabutylammonium (TBA) fluoride the deprotonation of the carboxylic acid moieties was observed.

View Article and Find Full Text PDF

Background: This study evaluates the efficacy of gabexate mesylate thermosensitive in-situ gel (GMTI) in the treatment of beagle grade III pancreatic trauma (PT) with the assistance of contrast-enhanced ultrasound (CEUS) and investigates its mechanism of action.

Methods: A grade III PT model consisting of 15 beagle dogs with severed main pancreatic ducts was created and treated with cephalic vein injection of gabexate mesylate (GM) (1.54 mL/10 kg, TID) and peripancreatic injection of GMTI (4.

View Article and Find Full Text PDF

Formulation Advances in Posterior Segment Ocular Drug Delivery.

J Ocul Pharmacol Ther

January 2025

Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.

Posterior segment ocular diseases, such as diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion, are leading causes of vision impairment and blindness worldwide. Effective management of these conditions remains a formidable challenge due to the unique anatomical and physiological barriers of the eye, including the blood-retinal barrier and rapid drug clearance mechanisms. To address these hurdles, nanostructured drug delivery systems are proposed to overcome ocular barriers, target the retina, and enhance permeation while ensuring controlled release.

View Article and Find Full Text PDF

LaSrMnO Perovskites for Oxygen Reduction in Zn-Air Batteries: Enhanced by Glucose Regulation.

ACS Appl Mater Interfaces

January 2025

School of Mechanical Science and Engineering, Northeast Petroleum University, 199 Fazhan Road, Daqing 163318, P. R. China.

The actual ORR catalytic activity of perovskite materials is significantly lower than the theoretical value due to their inherently low specific surface area and significant segregation of inactive oxygen ions on the surface. This study reports a sol-gel synthesis approach that employs glucose as a structural regulator to fabricate LaSrMnO (LSM) perovskites. Compared with the original LSM (12.

View Article and Find Full Text PDF

Massive blood loss is the main cause of prehospital trauma-related death, the development of rapid and effective hemostatic materials is imminent. Injectable hydrogels have the advantages of covering irregular bleeding sites and quickly closing the wound. However, its inherent viscosity can easily precipitate tissue adhesion and other complications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!